SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Strongbridge Biopharma plc (SBBP) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 49/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SBBP
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio3.65
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.80
Book Value / Share$0.00
Revenue / Share$0.55
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.88 |
$0.00 |
$-5.3M |
- |
| 2014 |
$-0.96 |
$0.00 |
$-9.67M |
- |
| 2015 |
$-2.62 |
$0.00 |
$-43.58M |
- |
| 2016 |
$-2.24 |
$0.00 |
$-48.6M |
- |
| 2017 |
$-3.11 |
$7.05M |
$-113.48M |
-1610.6% |
| 2018 |
$0.64 |
$18.03M |
$31.85M |
176.7% |
| 2019 |
$-0.89 |
$21.71M |
$-49.45M |
-227.8% |
| 2020 |
$-0.80 |
$30.73M |
$-45.08M |
-146.7% |
